DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Emily Elconin - 1 BioNTech - 1 Caitlin Rivers - 1 Mandy Cohen - 1 Rivers - 1 bivalent - 1 Daniel Kuritzkes - 1 Eris - 1
Top related locs:
Waterford , Michigan U.S United States Baltimore Europe Asia Boston Moderna
Top related orgs:
REUTERS - 1 U.S . Centers for Disease Control - 1 Prevention - 1 U.S . Food - 1 Drug Administration - 1 Pfizer - 1 Moderna - 1 FDA - 1

Search resuls for: "Daniel Kuritzkes"


2 mentions found


☆ US CDC contemplates who should get the new COVID shots
  + stars: | 2023-09-12 | by ( Bhanvi Satija Julie Steenhuysen | Bhanvi Satija | Julie Steenhuysen | ) www.reuters.com   time to read: +4 min
The updated shots are part of a push by public health officials to align the next COVID vaccines more closely with the actual circulating variant of the virus, similar to the way annual flu shots are designed. The U.S. Food and Drug Administration (FDA) on Monday authorized updated COVID vaccines made by Pfizer (PFE.N) and its German partner BioNTech SE (22UAy.DE) as well as by Moderna (MRNA.O). CDC Director Mandy Cohen is expected to approve the recommendations issued by the advisers, allowing Americans to get the updated vaccines. The first COVID vaccines in 2020 were monovalent, or single-target vaccines, aimed at the original strain of the virus. They were followed by bivalent COVID vaccine booster shots that targeted both the original and the Omicron strains.
Persons: Emily Elconin, BioNTech, Caitlin Rivers, Mandy Cohen, Rivers, bivalent, Daniel Kuritzkes, Eris, Kuritzkes, Novavax, Bhanvi, Julie Steenhuysen, Will Dunham, Caroline Humer Organizations: REUTERS, U.S . Centers for Disease Control, Prevention, U.S . Food, Drug Administration, Pfizer, Moderna, FDA, Johns Hopkins Center for Health Security, CDC, Omicron, Brigham, Women's Hospital, Vaccine, EG, Thomson Locations: Waterford , Michigan, U.S, United States, Baltimore, Europe, Asia, Boston, Moderna, Bengaluru, Chicago
☆ Emerging from the COVID pandemic, again
  + stars: | 2022-12-07 | by ( Michele Gershberg | ) www.reuters.com   time to read: +4 min
Dec 7 (Reuters) - For much of the world, 2022 marked the beginning of the end of the COVID-19 pandemic. Emerging variations of the coronavirus so far remain closely related to Omicron, without radically altering its impact. "The pandemic is over," U.S. President Joe Biden said in September, referring to the changing behavior of Americans. The World Health Organization (WHO) has yet to declare an end to the COVID public health emergency introduced in January 2020. Data show that the pandemic has disrupted all kinds of healthcare, from childhood immunizations to cancer screenings read more read more .
0 next >>
Total: 2